NCT05938296 2025-11-19oHSV2-PD-L1/CD3-BsAb Administered Via Intratumoral InjectionBinhui Biopharmaceutical Co., Ltd.Phase 1 Suspended29 enrolled
NCT04381806 2025-10-29Phase I Study in Advanced Malignancies With 5-ALAFox Chase Cancer CenterPhase 1 Suspended130 enrolled